Showing results (1-10 of 67) with videos related to
Sort By:
Pageof 7
Toxins|September 26, 2025
Intermittent Infusion Hemodiafiltration: A Narrative Review of an Emerging Dialysis ModalityXiaoxi Zhou, Jing Sun, Lining MiaoDiabetes/Metabolism Research and Reviews|February 11, 2011
Pulmonary fibrosis: a possible diabetic complicationJunling Yang, Qianfei Xue, Lining Miao, et al.Experimental Diabetes Research|May 31, 2012
Prevention of diabetic complications by activation of Nrf2: diabetic cardiomyopathy and nephropathyBing Li, Shujun Liu, Lining Miao, et al.Frontiers in Physiology|May 28, 2026
Mitophagy in kidney and lung epithelial cells: molecular mechanisms, crosstalk, and therapeutic interventionsXiaoxi Zhou, Jing Sun, Lining Miao, et al.Frontiers of Medicine|February 7, 2013
Zinc homeostasis in the metabolic syndrome and diabetesXiao Miao, Weixia Sun, Yaowen Fu, et al.Oxidative Medicine and Cellular Longevity|March 28, 2013
Preventive and therapeutic effects of MG132 by activating Nrf2-ARE signaling pathway on oxidative stress-induced cardiovascular and renal injuryWenpeng Cui, Yang Bai, Ping Luo, et al.Nephrology (Carlton, Vic.)|October 4, 2006
Combined therapy of low-dose tacrolimus and prednisone in nephrotic syndrome with slight mesangial proliferationLining Miao, Jing Sun, Hang Yuan, et al.Life Sciences|August 2, 2020
Sulforaphane suppresses obesity-related glomerulopathy-induced damage by enhancing autophagy via Nrf2Yue Lu, Yixian Zhang, Yan Lou, et al.Journal of Diabetes Research|October 1, 2015
Potential Renoprotective Agents through Inhibiting CTGF/CCN2 in Diabetic NephropathySongyan Wang, Bing Li, Chunguang Li, et al.The Journal of International Medical Research|April 10, 2013
Nuclear factor (erythroid-derived 2)-like 2 (NFE2L2) is a novel therapeutic target for diabetic complicationsXiaohong Xu, Ping Luo, Yangwei Wang, et al.Pageof 7